EyeGate Pharma Announces Positive Results in Second PRK Study

Go back to EyeGate Pharma Announces Positive Results in Second PRK Study
(NASDAQ: EYEG) Delayed: 34.56 -0.1 (0.29%)
Previous Close $34.66    52 Week High $5.09 
Open $34.56    52 Week Low $1.11 
Day High $34.56    P/E N/A 
Day Low $34.56    EPS $0.00 
Volume 62